Einar Ottestad, MD
Pain Management · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 4
Offices
4 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ottestad’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A92865 · Current
Licensed to practise in California · since 2005 · expires 2027-07-31 · Baylor College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$63,224
Medicare paid this office $63,224 for 384 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 144 | $19,012 | $70 |
| Return visit (30+ min) | 61 | $6,530 | $99 |
| Short return visit (20+ min) | 47 | $3,722 | $73 |
| New patient visit (60+ min) | 22 | $3,501 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,480 | $106 |
See all 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 144 | $19,012 | $70 |
| Return visit (30+ min) | 61 | $6,530 | $99 |
| Short return visit (20+ min) | 47 | $3,722 | $73 |
| New patient visit (60+ min) | 22 | $3,501 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,480 | $106 |
| Short return visit | 28 | $1,476 | $41 |
| New patient visit (45+ min) | 11 | $1,343 | $122 |
| New patient visit (30+ min) | 16 | $1,279 | $80 |
| Ultrasonic guidance for needle placement | 31 | $900 | $26 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 22 | $892 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 33 | $344 | $10 |
Who their Medicare patients are
384 Original Medicare patients in 2024. Average age 72 · Under 65 15% · 85 and older 12% · Women 61% · Also on Medicaid 21% · Health risk score 1.62. Above the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 73% · Depression 33% · Diabetes 29% · Coronary heart disease 29% · Chronic kidney disease 25% · Atrial fibrillation 24% · Heart failure 21% · Cancer 17% · COPD 17% · Stroke 9% · Dementia 8%.
The office billed $960,106, Medicare allowed $80,956 and paid $63,224; for 782 services of 60 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 384 | 782 | 72 | 1.62 | $960,106 | $63,224 |
| 2023 | 363 | 733 | 72 | 1.69 | $735,099 | $54,404 |
| 2022 | 397 | 762 | 70 | 1.65 | $633,694 | $53,080 |
| 2021 | 392 | 798 | 70 | 1.99 | $765,737 | $59,271 |
| 2020 | 464 | 925 | 69 | 1.73 | $645,676 | $73,164 |
| 2019 | 425 | 937 | 69 | 1.52 | $678,530 | $74,465 |
| 2018 | 486 | 1,117 | 69 | 1.80 | $556,983 | $84,072 |
| 2017 | 468 | 1,139 | 70 | 1.72 | $676,225 | $82,979 |
| 2016 | 485 | 1,207 | 68 | 1.87 | $675,625 | $83,857 |
| 2015 | 521 | 1,297 | 69 | 1.64 | $683,353 | $87,923 |
| 2014 | 538 | 1,285 | 69 | 1.57 | $560,982 | $87,674 |
| 2013 | 487 | 1,079 | 68 | 1.50 | $484,560 | $71,994 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 147 | $19,936 | $73 |
| Return visit (30+ min) | 48 | $4,635 | $86 |
| Short return visit (20+ min) | 34 | $2,261 | $54 |
| New patient visit (45+ min) | 17 | $2,018 | $119 |
| Long return visit (40+ min) | 14 | $1,809 | $129 |
| New patient visit (60+ min) | 11 | $1,807 | $164 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,285 | $76 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 21 | $882 | $37 |
| New patient visit (30+ min) | 13 | $859 | $66 |
| Ultrasonic guidance for needle placement | 31 | $820 | $25 |
| Injection of trigger points, 3 or more muscles | 17 | $566 | $30 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 20 | $108 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 24 | $104 | $4 |
2022: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 128 | $13,528 | $62 |
| Return visit (30+ min) | 48 | $4,361 | $79 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 46 | $4,275 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,130 | $92 |
| Long return visit (40+ min) | 20 | $2,489 | $119 |
| New patient visit (60+ min) | 11 | $1,744 | $159 |
| Short return visit (20+ min) | 23 | $1,502 | $60 |
| New patient visit (45+ min) | 12 | $1,341 | $112 |
| Ultrasonic guidance for needle placement | 39 | $1,142 | $26 |
| New patient visit (30+ min) | 14 | $1,041 | $74 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 18 | $724 | $34 |
| Injection of trigger points, 1-2 muscles | 18 | $631 | $33 |
| Injection of trigger points, 3 or more muscles | 14 | $619 | $39 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 34 | $162 | $4 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 12 | $57 | $5 |
2021: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 129 | $15,087 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 69 | $6,542 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,224 | $96 |
| New patient visit (60+ min) | 14 | $2,353 | $168 |
| Return visit (30+ min) | 26 | $2,217 | $82 |
| Ultrasonic guidance for needle placement | 64 | $1,872 | $27 |
| Short return visit (20+ min) | 28 | $1,627 | $56 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 17 | $643 | $34 |
| Injection of trigger points, 1-2 muscles | 15 | $486 | $32 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 32 | $476 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 12 | $58 | $5 |
2020: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 190 | $22,761 | $67 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 109 | $10,926 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $7,218 | $98 |
| New patient visit (60+ min) | 32 | $4,643 | $145 |
| Return visit (30+ min) | 50 | $3,701 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,051 | $121 |
| New patient visit (45+ min) | 13 | $1,457 | $112 |
| Ultrasonic guidance for needle placement | 37 | $1,064 | $27 |
| Short return visit (20+ min) | 23 | $971 | $42 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 12 | $617 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $346 | $12 |
2019: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 185 | $20,933 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 140 | $13,718 | $91 |
| Return visit (30+ min) | 58 | $4,850 | $67 |
| New patient visit (60+ min) | 22 | $2,637 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,792 | $94 |
| Destruction of peripheral nerve or branch | 12 | $1,638 | $102 |
| Long return visit (40+ min) | 20 | $1,530 | $73 |
| Ultrasonic guidance for needle placement | 44 | $1,527 | $28 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,361 | $113 |
| New patient visit (45+ min) | 12 | $1,154 | $96 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 17 | $746 | $41 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $493 | $12 |
2018: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 224 | $25,229 | $64 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 187 | $16,886 | $88 |
| Return visit (30+ min) | 54 | $4,472 | $68 |
| New patient visit (60+ min) | 21 | $3,034 | $144 |
| Long return visit (40+ min) | 26 | $2,632 | $97 |
| Ultrasonic guidance for needle placement | 57 | $1,854 | $27 |
| New patient visit (45+ min) | 15 | $1,598 | $107 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $1,030 | $61 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 21 | $955 | $38 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $536 | $11 |
| Injection of trigger points, 3 or more muscles | 11 | $451 | $38 |
| Injection of trigger points, 1-2 muscles | 14 | $422 | $30 |
2017: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 218 | $26,233 | $64 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 194 | $18,230 | $89 |
| Return visit (30+ min) | 56 | $4,670 | $63 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 11 | $2,510 | $209 |
| New patient visit (45+ min) | 17 | $1,847 | $109 |
| Ultrasonic guidance for needle placement | 59 | $1,830 | $28 |
| New patient visit (60+ min) | 12 | $1,618 | $135 |
| Destruction of peripheral nerve or branch | 13 | $1,281 | $92 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 19 | $935 | $43 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 11 | $801 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 48 | $683 | $12 |
| Injection of trigger points, 1-2 muscles | 19 | $585 | $29 |
2016: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 170 | $20,579 | $64 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 177 | $16,932 | $89 |
| Return visit (30+ min) | 61 | $4,591 | $62 |
| New patient visit (60+ min) | 30 | $4,466 | $149 |
| Destruction of peripheral nerve or branch | 26 | $3,117 | $97 |
| Daily hospital management of continuous spinal drug administration | 27 | $2,922 | $53 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 55 | $2,756 | $37 |
| Ultrasonic guidance for needle placement | 71 | $2,743 | $29 |
| New patient visit (45+ min) | 20 | $2,194 | $110 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 34 | $1,968 | $46 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 13 | $918 | $54 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 19 | $778 | $39 |
| Injection of trigger points, 3 or more muscles | 12 | $504 | $36 |
2015: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 202 | $22,573 | $64 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 151 | $13,858 | $89 |
| Daily hospital management of continuous spinal drug administration | 69 | $10,158 | $57 |
| Return visit (30+ min) | 48 | $3,815 | $67 |
| New patient visit (45+ min) | 25 | $2,777 | $111 |
| Ultrasonic guidance for needle placement | 80 | $2,724 | $29 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 58 | $2,518 | $38 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 39 | $1,978 | $40 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,707 | $122 |
| Destruction of peripheral nerve or branch | 14 | $1,666 | $88 |
| Hospital discharge day management, 30 minutes or less | 14 | $928 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $626 | $35 |
| Short return visit (20+ min) | 11 | $454 | $38 |
2014: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 212 | $21,598 | $63 |
| Daily hospital management of continuous spinal drug administration | 80 | $11,083 | $57 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 114 | $10,445 | $89 |
| Ultrasonic guidance for needle placement | 91 | $3,715 | $29 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,530 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,773 | $92 |
| Return visit (30+ min) | 33 | $2,520 | $65 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 43 | $1,959 | $38 |
| New patient visit (45+ min) | 17 | $1,789 | $105 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 32 | $1,724 | $39 |
| Injection of trigger points, 1-2 muscles | 23 | $775 | $30 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $694 | $35 |
| Aspiration and/or injection of fluid from large joint | 15 | $683 | $40 |
| Short return visit (20+ min) | 13 | $546 | $39 |
| Injection of trigger points, 3 or more muscles | 12 | $471 | $36 |
| Fluoroscopic guidance for spine or back muscle injection | 14 | $351 | $25 |
2013: 17 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 169 | $17,723 | $62 |
| Daily hospital management of continuous spinal drug administration | 76 | $8,272 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $5,653 | $88 |
| Ultrasonic guidance for needle placement | 87 | $2,944 | $28 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,684 | $117 |
| Return visit (30+ min) | 28 | $2,634 | $63 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 41 | $1,803 | $38 |
| New patient visit (60+ min) | 11 | $1,594 | $145 |
| New patient visit (45+ min) | 14 | $1,590 | $114 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 31 | $1,576 | $39 |
| Long return visit (40+ min) | 14 | $1,339 | $96 |
| Injections of substances into lower or sacral spine | 14 | $1,034 | $74 |
| Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | 15 | $946 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $745 | $34 |
| Aspiration and/or injection of fluid from large joint | 18 | $707 | $37 |
| Injection of trigger points, 1-2 muscles | 21 | $698 | $30 |
| Fluoroscopic guidance for spine or back muscle injection | 22 | $595 | $25 |
Medicaid work
$4,141 in 2024
Medicaid paid $4,141 for 164 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 164 | $4,141 |
| 2024 | 164 | 1 | 30 | $4,141 |
| 2023 | 185 | 1 | 25 | $4,618 |
| 2022 | 71 | 1 | 14 | $2,326 |
| 2021 | 75 | 1 | 21 | $2,241 |
| 2020 | 165 | 1 | 21 | $5,194 |
| 2019 | 53 | 1 | 15 | $1,697 |
| 2018 | 110 | 2 | 14 | $3,840 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 185 | $4,618 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 71 | $2,326 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 75 | $2,241 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 165 | $5,194 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 53 | $1,697 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 85 | $2,554 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 25 | $1,286 |
Drugs they prescribed that Part D paid
$6,479
Pharmacies billed $6,479 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 38% of their Part D prescriptions (44 of 117) in 2024. At or below the middle of the specialty; the typical pain management clinician is at 44%. Long-acting opioids: 41% of their opioid prescriptions.
112 generic and fewer than 11 brand-name prescriptions · $6,479 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pregabalin | 13 | $901 | $69 |
| Gabapentin | 23 | $477 | $21 |
| Oxycodone | 12 | $177 | $15 |
| Methadone | 15 | $116 | $8 |
Year by year
| 2024 | 117 | 34 | 38% (44) | None | $6,479 |
| 2023 | 88 | 29 | 33% (29) | None | $2,601 |
| 2022 | 64 | 23 | None | None | $5,043 |
| 2021 | 58 | 23 | 29% (17) | None | $4,995 |
| 2020 | 130 | 35 | 37% (48) | 21% | $14,989 |
| 2019 | 138 | 40 | 12% (17) | 24% | $19,858 |
| 2018 | 181 | 71 | 19% (35) | 18% | $21,690 |
| 2017 | 177 | 67 | 11% (19) | 18% | $21,206 |
| 2016 | 230 | 81 | 15% (35) | 18% | $23,539 |
| 2015 | 189 | 62 | 25% (48) | 11% | $15,203 |
| 2014 | 138 | 37 | 20% (27) | 10% | $7,794 |
| 2013 | 157 | 49 | 19% (29) | 33% | $17,200 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Pregabalin | 14 | $636 | $45 |
| Gabapentin | 15 | $528 | $35 |
| Duloxetine | 11 | $175 | $16 |
| Methadone | 13 | $165 | $13 |
2022: 1 drug
| Pregabalin | 19 | $506 | $27 |
2020: 3 drugs
| Buprenorphine | 20 | $7,007 | $350 |
| Pregabalin | 23 | $1,182 | $51 |
| Gabapentin | 17 | $439 | $26 |
2019: 2 drugs
| Lyrica | 19 | $10,552 | $555 |
| Gabapentin | 43 | $1,020 | $24 |
2018: 6 drugs
| Lyrica | 14 | $7,708 | $551 |
| Gabapentin | 39 | $1,309 | $34 |
| Duloxetine | 18 | $714 | $40 |
| Sumatriptan | 11 | $199 | $18 |
| Hydrocodone-Acetaminophen | 12 | $163 | $14 |
| Cephalexin | 14 | $57 | $4 |
2017: 5 drugs
| Lyrica | 13 | $8,155 | $627 |
| Gabapentin | 24 | $810 | $34 |
| Duloxetine | 14 | $774 | $55 |
| Sumatriptan | 12 | $246 | $20 |
| Cephalexin | 16 | $94 | $6 |
2016: 4 drugs
| Lyrica | 24 | $11,710 | $488 |
| Duloxetine | 19 | $2,682 | $141 |
| Gabapentin | 77 | $1,589 | $21 |
| Desipramine | 12 | $1,099 | $92 |
2015: 4 drugs
| Duloxetine | 20 | $3,086 | $154 |
| Gabapentin | 49 | $961 | $20 |
| Nortriptyline | 16 | $272 | $17 |
| Tramadol | 12 | $147 | $12 |
2014: 2 drugs
| Gabapentin | 44 | $1,328 | $30 |
| Tramadol | 11 | $215 | $20 |
2013: 2 drugs
| Cymbalta | 14 | $4,949 | $354 |
| Gabapentin | 42 | $1,671 | $40 |
Money from drug and device companies
$24,245 in 2025
| 2025 | 7 | 29 | $18,400 | $24,245 |
| 2024 | 7 | 55 | $26,725 | $37,518 |
| 2023 | 8 | 70 | $68,750 | $81,013 |
| 2022 | 8 | 68 | $57,500 | $66,132 |
| 2021 | 7 | 37 | $17,250 | $42,465 |
| 2020 | 5 | 14 | $4,725 | $12,655 |
| 2019 | 5 | 40 | $12,255 | $88,202 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
Tulavi Therapeutics, Inc.
$14,431
Held by this doctor · 2025 · Physician Holds Stock Options Granted Under the Companys Equity Incentive Plan. Options Provide the Right To Purchase Common Shares at the Grant Exercise Price, Subject To A Time Based Vesting Schedule. No Special Terms, Accelerated Vesting Rights, Or Preferential Conditions Were Provided.
Published ownership or investment in a drug or device company. This is not proof that care is biased.
A payment is not proof that care is biased.
| SPR Therapeutics | Sprint Pns System | $13,518 | 16 payments
|
| Coloplast | None | $8,400 | 1 payment
|
| Bioventus | Stimrouter Implantable Kit | $1,263 | 5 payments
|
| Biotronik Nro | Prospera | $680 | 4 payments
|
| Medtronic | Intellis Adaptivestim | $167 | 1 payment
|
| Abbott Laboratories | Proclaim | $114 | 1 payment
|
See all 29 published payments
| SPR Therapeutics | Consulting · 2025-12-18 | Sprint Pns System | $5,000 |
| SPR Therapeutics | Travel · 2025-12-18 | Sprint Pns System | $577 |
| SPR Therapeutics | Travel · 2025-12-15 | Sprint Pns System | $151 |
| SPR Therapeutics | Travel · 2025-12-01 | Sprint Pns System | $9 |
| SPR Therapeutics | Travel · 2025-12-01 | Sprint Pns System | $324 |
| SPR Therapeutics | Meals · 2025-11-14 | Sprint Pns System | $23 |
| SPR Therapeutics | Consulting · 2025-10-23 | Sprint Pns System | $1,000 |
| SPR Therapeutics | Consulting · 2025-10-15 | Sprint Pns System | $4,000 |
| SPR Therapeutics | Travel · 2025-10-15 | Sprint Pns System | $1,546 |
| SPR Therapeutics | Travel · 2025-10-03 | Sprint Pns System | $212 |
| Bioventus | Travel · 2025-09-29 | Stimrouter Implantable Kit | $221 |
| Bioventus | Meals · 2025-09-26 | None | $164 |
| Bioventus | Travel · 2025-09-26 | Stimrouter Implantable Kit | $124 |
| SPR Therapeutics | Meals · 2025-09-19 | Sprint Pns System | $88 |
| Abbott Laboratories | Meals · 2025-09-19 | Proclaim | $114 |
| Boston Scientific | Meals · 2025-09-18 | General - Pain Management | $104 |
| Biotronik Nro | Meals · 2025-09-18 | Prospera | $149 |
| Biotronik Nro | Meals · 2025-09-16 | Prospera | $172 |
| Bioventus | Travel · 2025-09-09 | Stimrouter Implantable Kit | $643 |
| SPR Therapeutics | Meals · 2025-09-06 | Sprint Pns System | $134 |
| SPR Therapeutics | Meals · 2025-09-06 | Sprint Pns System | $25 |
| SPR Therapeutics | Meals · 2025-09-05 | Sprint Pns System | $118 |
| SPR Therapeutics | Meals · 2025-08-08 | Sprint Pns System | $87 |
| SPR Therapeutics | Travel · 2025-08-05 | Sprint Pns System | $224 |
| Medtronic | Meals · 2025-07-18 | Intellis Adaptivestim | $167 |
| Biotronik Nro | Meals · 2025-07-18 | Prospera | $142 |
| Coloplast | Consulting · 2025-04-17 | None | $8,400 |
| Bioventus | Meals · 2025-04-16 | Stimrouter Implantable Kit | $111 |
| Biotronik Nro | Meals · 2025-02-26 | Prospera | $218 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $37,518
| SPR Therapeutics | Sprint Pns System | $28,455 | 28 payments
|
| Bioventus | Stimrouter Implantable Kit | $6,645 | 12 payments
|
| Coloplast | None | $1,197 | 6 payments
|
| Painteq | Painteq | $431 | 5 payments
|
| Rivanna Medical | Accuro | $350 | 1 payment
|
| Biotronik Nro | Prospera | $268 | 2 payments
|
| Abbott Laboratories | Eterna | $171 | 1 payment
|
2023: $81,013
| Bioventus | Stimrouter Implantable Kit | $50,069 | 17 payments
|
| SPR Therapeutics | Sprint Pns System | $21,687 | 22 payments
|
| Pacira Pharmaceuticals | Iovera | $5,405 | 8 payments
|
| Coloplast | None | $3,227 | 19 payments
|
| Painteq | Painteq | $242 | 1 payment
|
| Biotronik Nro | Biotronik | $173 | 1 payment
|
| Nevro | Senza | $136 | 1 payment
|
| Stratus Medical | Nimbus | $72 | 1 payment
|
2022: $66,132
| Bioventus | Stimrouter Implantable Kit | $29,932 | 13 payments
|
| SPR Therapeutics | Sprint Pns System | $22,921 | 20 payments
|
| Medtronic | None | $10,664 | 12 payments
|
| Coloplast | None | $2,393 | 11 payments
|
| Nalu Medical | Nalu Neurostimulation System | $141 | 1 payment
|
| Painteq | Painteq | $37 | 1 payment
|
| Abbott Laboratories | Proclaim | $23 | 1 payment
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $20 | 3 payments
|
2021: $42,465
| Bioness | Stimrouter for Pain | $22,872 | 2 payments
|
| SPR Therapeutics | Sprint Pns System | $17,380 | 8 payments
|
| Bioventus | None | $1,250 | 1 payment
|
| Coloplast | Titan | $590 | 8 payments
|
| Abbott Laboratories | Proclaim Ipg | $266 | 10 payments
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W Receiver | $62 | 1 payment
|
| Relievant Medsystems | Intracept | $44 | 2 payments
|
2020: $12,655
| SPR Therapeutics | Sprint Pns System | $6,870 | 2 payments
|
| Nalu Medical | Nalu Neurostimulation System | $4,725 | 3 payments
|
| Bioness | Stimrouter for Pain | $823 | 1 payment
|
| Abbott Laboratories | Prodigy Family of Scs Ipgs | $150 | 2 payments
|
| Si-Bone | Ifuse Implant | $87 | 1 payment
|
2019: $88,202
| Bioness | Stimrouter for Pain | $63,104 | 2 payments
|
| Ipsen Innovation | Dysport | $23,942 | 6 payments
|
| SPR Therapeutics | Sprint Pns System | $753 | 3 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $269 | 2 payments
|
| Abbott Laboratories | Prodigy Family of Scs Ipgs | $134 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Bioventus LLC · A Prospective, Open-Label,Long-Term, Multi-Center, Registry To Assess the Safety and Efficacy of the Bioness Stimrouter Neuromodulation System in Subjects With Chronic Pain of Peripheral Nerve Origin · 2022 | This clinician | $26,459 |
| COLOPLAST CORP · Intibia Pivotal Study · 2022 | This clinician | $19,600 |
| Bioventus LLC · A Prospective, Open-Label,Long-Term, Multi-Center, Registry To Assess the Safety and Efficacy of the Bioness Stimrouter Neuromodulation System in Subjects With Chronic Pain of Peripheral Nerve Origin · 2023 | This clinician | $14,764 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1609076983
- Licence
- CA A92865California A92865: Current · expires 2027-07-31
- Trained
- Baylor College of Medicine, 2002
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 207L00000X (207L00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94305
- NPI first listed
- 2007-07-24
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.